Why sepsis is becoming harder to treat in Europe
Sepsis moves fast. A patient can arrive at hospital with what appears to be a routine infection and, within hours, develop organ failure. Survival...
Clarifying how ketogenic diets treat epilepsy to guide future therapy development
Published in The Lancet Neurology, a new review from the University of Colorado Anschutz in collaboration with UT Southwestern Medical Center, offers...
A new tool to predict physical health risks in young people with psychosis
A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing...
Breast cancer stage at diagnosis differs sharply across rural US regions
Where a woman lives significantly affects whether her breast cancer is diagnosed at an early or late stage, according to a national analysis published...
New atlas maps aging brain epigenetic shifts across eight regions and 36 cell types
Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and...
How chaos theory could turn every NHS scan into its own fortress
Fresh research from the University of East Anglia (UEA) could transform how the NHS protects patients' medical images from cyberattacks. Computer...
Prior authorization may hinder access to lifesaving heart failure medications
Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep...
New malaria vaccine shows promise in preclinical trials
Malaria is caused by a parasite that is spread to humans by infected mosquitoes. In 2024, almost 282 million people worldwide were infected and 610,000...
Cosmetic procedures need tighter regulation to reduce harm, argue experts
The rise in invasive cosmetic procedures demands tighter regulation, better consumer protection, and greater awareness to protect patient safety and...
Seaweed has the potential to create a shield to block norovirus infection
To date, there are no approved vaccines or antiviral treatments for human norovirus, the leading cause of acute gastroenteritis outbreaks worldwide...
